Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
IntuiSkin is a French technology-driven skincare company that operates the prestige brand IOMA Paris. The company is a pioneer in "Evidence-Based Cosmetics," utilizing advanced Micro-Electro-Mechanical Systems (MEMS) and skin imaging sensors to diagnose specific dermatological conditions. Their proprietary diagnostic platforms, such as the IOMA Sphere, provide a comprehensive analysis of skin hydration, UV damage, and fine lines to guide treatment. Based on these digital diagnostics, IntuiSkin offers personalized skincare formulations tailored to the specific needs of the individual user. Founded by tech entrepreneur Jean Michel Karam, the company bridges the gap between microelectronics and dermatology. In 2012, Unilever acquired a majority stake in IntuiSkin to lead its prestige and personalized beauty segment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on IntuiSkin.